New Diabetes drug a success, says Eli Lilly

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

A new drug from Eli Lilly to treat Type-2 Diabetes is one step closer to hitting the market.

The drug maker said the Dulaglutide met its goals in a pair of late-phase studies.

The drug is a once-a-week injection that lowers blood glucose. Right now, some people with Type 2 Diabetes face multiple injections a day.

The new drug has been under development for more than six years.

Lilly expects to submit it to regulatory authorities later this year.